Communiqués Cognos Therapeutics Holdings, Inc.

Actions

MBTC

KYG6580S1140

Sociétés holdings

Marché Fermé - Nasdaq 22:00:00 03/04/2024			Varia. 5j.	Varia. 1 janv.
11,66 ^USD	-0,49%		-.--%	-

31/03/24	Cognos Therapeutics Inc. a annulé l'acquisition de Nocturne Acquisition Corporation (NasdaqCM:MBTC) auprès d'un groupe d'actionnaires dans le cadre d'une opération de fusion inversée.	CI
07/02/24	Nocturne Acquisition Corporation annonce des changements de direction	CI

Communiqués

21/09/23	Chardan Engaged to Facilitate Nocturne Acquisition Corporation's Business Combination with Cognos Therapeutics, Inc., Paving the Way for NASDAQ Listing	AQ
02/05/23	NOCTURNE ACQUISITION CORP : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)	AQ
14/04/23	NOCTURNE ACQUISITION CORP : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	AQ
06/04/23	NOCTURNE ACQUISITION CORP : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)	AQ
03/04/23	NOCTURNE ACQUISITION CORP : Regulation FD Disclosure (form 8-K)	AQ
09/01/23	NOCTURNE ACQUISITION CORP : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	AQ
04/01/23	NOCTURNE ACQUISITION CORP : Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	AQ
21/11/22	NOCTURNE ACQUISITION CORP Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	AQ
05/10/22	NOCTURNE ACQUISITION CORP : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)	AQ
22/08/22	NOCTURNE ACQUISITION CORP Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	AQ
05/07/22	Nocturne Acquisition : Confirms Funding to Extend Period to Consummate Initial Business Combination - Form 8-K	PU
05/07/22	NOCTURNE ACQUISITION CORP : Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	AQ
17/05/22	NOCTURNE ACQUISITION CORP Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	AQ
05/04/22	Nocturne Acquisition : Confirms Funding to Extend Period to Consummate Initial Business Combination - Form 8-K	PU
05/04/22	NOCTURNE ACQUISITION CORP : Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	AQ
31/03/22	NOCTURNE ACQUISITION CORP Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	AQ
20/12/21	NOCTURNE ACQUISITION CORP : Change in Directors or Principal Officers (form 8-K)	AQ
19/11/21	NOCTURNE ACQUISITION CORP : Non-Reliance on Previous Financials, Audits or Interim Review (form 8-K)	AQ
18/11/21	NOCTURNE ACQUISITION CORP Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	AQ
16/08/21	NOCTURNE ACQUISITION : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	AQ
23/06/21	NOCTURNE ACQUISITION : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	AQ
04/06/21	Nocturne Acquisition : Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q (Form 8-K)	PU
04/06/21	NOCTURNE ACQUISITION CORP : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events, Financial Statements and Exhibits (form 8-K)	AQ